• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Concentrix Corporation

    9/24/24 4:35:52 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology
    Get the next $CNXC alert in real time by email
    DEFA14A 1 defa14a-additionalproxymat.htm DEFA14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
    Proxy Statement Pursuant to Section 14(a)
    of the Securities Exchange Act of 1934
    Filed by the Registrant ☒
    Filed by a Party other than the Registrant ☐
    Check the appropriate box:
    ☐ Preliminary Proxy Statement
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐ Definitive Proxy Statement
    ☒ Definitive Additional Materials
    ☐ Soliciting Material Pursuant to §240.14a-12


    Concentrix Corporation
    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):
    ☒ No fee required.
    ☐ Fee paid previously with preliminary materials.
    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
    ____________________________________________________________________________________________________
    (3) Filing Party:
    ____________________________________________________________________________________________________
    (4) Date Filed:
    ____________________________________________________________________________________________________




    cnx_fullcolorseptember2024.jpg

    Supplement to Proxy Statement
    For the Special Meeting of Stockholders
    To be held on October 28, 2024

    This supplement (the “Supplement”) amends and supplements the definitive proxy statement on Schedule 14A (the “Proxy Statement”) filed by Concentrix Corporation (the “Company”) with the U.S. Securities and Exchange Commission relating to the Company’s Special Meeting of Stockholders (the “Special Meeting”) to be held on October 28, 2024.

    After the Company filed its Proxy Statement, one purported stockholder of the Company sent the Company a demand letter asserting that the Proxy Statement’s description of the vote required for approval of Proposal Nos. 2 and 3, and the effect of abstentions on the vote, is “confusingly inconsistent.” While the Company believes that the alleged inconsistencies in the Proxy Statement are immaterial, to moot this disclosure claim, avoid nuisance and business delays, and provide additional information to its stockholders, the Company has determined to voluntarily amend certain disclosures in the Proxy Statement with the supplemental disclosures set forth below (the “Supplemental Disclosures”) under the heading “Supplemental Disclosures to the Proxy Statement.” Nothing in the Supplemental Disclosures shall be deemed an admission of the legal merit, necessity or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, the Company specifically denies all allegations that any additional disclosure was or is required or material.

    Other than the Supplemental Disclosures listed below, the Proxy Statement remains unchanged, and this Supplement does not otherwise amend, supplement, or affect the Proxy Statement. From and after the date of this Supplement, any references to the “Proxy Statement” are to the Proxy Statement as amended and supplemented by this Supplement. This Supplement should be read in conjunction with the Proxy Statement and the other proxy materials previously made available to stockholders in connection with the Special Meeting. If you have already voted your shares, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal.

    Supplemental Disclosures to the Proxy Statement

    The text under “About the Special Meeting—How to Vote at the Special Meeting—Beneficial Owners” section of the Proxy Statement is amended and restated in its entirety to read as follows (amendments are marked, with new text bold and underlined, and deleted text bold and stricken through):

    Beneficial Owners. If you hold your shares of Common Stock in a brokerage account or through a bank or other nominee, your broker, bank, or other nominee is considered the “stockholder of record” and you are considered the “beneficial owner” of the shares. In this case, your broker, bank, or other nominee is responsible for providing you with instructions on how to vote. If you are a beneficial owner and want to vote your shares of Common Stock at the virtual Special Meeting, you will need the unique 16-digit control number that appears on the instructions that accompanied the notice of internet availability or the proxy materials that you received.

    A broker non-vote occurs when (i) the bank, broker, trust or other nominee has discretionary voting power on routine proposals to be considered at a meeting of stockholders but does not have discretionary voting power on other proposals to be considered at such meeting because they are non-routine and (ii) the bank, broker, trust or other nominee has not received voting instructions from the beneficial owner on a non-routine proposal. A bank, broker, trust or other nominee may exercise discretion in voting on routine matters but may not exercise



    discretion, and therefore cannot vote, on non-routine matters if voting instructions are not provided by the beneficial owner on such non-routine matters.

    Each of the proposals, the Charter Amendment (Proposal 1), the 2020 Plan Proposal (Proposal 2), and the Adjournment Proposal (Proposal 3) to be considered at this Special Meeting are considered “non-routine” matters. Therefore, if you are a beneficial owner and you do not instruct your bank, broker, bank, trust or other nominee on how to vote your shares of Common Stock with respect to a specific proposal, it will not be permitted to vote your shares on such proposal. (resulting in a “broker non-vote”) on each of the proposals.

    The text under “About the Special Meeting—Quorum” section of the Proxy Statement is amended and restated in its entirety to read as follows (amendment are marked, with new text bold and underlined, and deleted text bold and stricken through):

    We will have a quorum to conduct business at the Special Meeting if holders of a majority of the outstanding shares of Common Stock entitled to vote as of the close of business on the record date are present or represented by proxy at the meeting. In determining a quorum, shares of Common Stock held by stockholders who abstain from voting or whose shares are represented by broker non-votes on any proposal will be considered present at the Special Meeting. Abstentions will be counted as present and entitled to vote for purposes of determining the presence of a quorum at the Special Meeting. As there are no routine proposals to be considered at the Special Meeting, we do not anticipate any broker non-votes. If you do not instruct your bank, broker, trust or other nominee on how to vote your shares of Common Stock with respect to any proposal or any particular proposal, your shares will not be considered entitled to vote or present or represented by proxy at the meeting for purposes of such proposal(s).

    The table included in the “About the Special Meeting – Required Votes” section of the Proxy Statement is amended and restated in its entirety to read as follows (amendments are marked, with new text bold and underlined, and deleted text bold and stricken through):

    ProposalBoard RecommendationVote Required to Adopt the ProposalEffect of Abstentions Effect of Broker Non-Votes
    Charter AmendmentFOR66-2/3% of shares entitled to vote generally in the election of directors*Same effect as vote against
    Same effect as vote against
    2020 Plan ProposalFOR
    Majority of all votes cast shares entitled to vote and present or represented by proxy at the Special Meeting
    Same effect as vote againstNo effect
    Adjournment ProposalFOR
    Majority of all votes cast shares entitled to vote and present or represented by proxy at the Special Meeting
    Same effect as vote againstNo effect
    *     79,561 shares of restricted Common Stock were issued in connection with the Webhelp combination for which holders have waived their right to vote on any matter submitted to the holders of Common Stock. As these shares are not entitled to vote generally in the election of directors, those shares will have no effect with respect to the Charter Amendment proposal.

    The text under “Proposal No. 2: Approval of Amended and Restated 2020 Stock Incentive Plan – Required Vote” section of the Proxy Statement is amended and restated in its entirety to read as follows (amendments are marked, with new text bold and underlined, and deleted text bold and stricken through):




    The effectiveness of the proposed Amended and Restated 2020 Plan is contingent upon stockholder approval. If our stockholders do not approve the 2020 Plan Proposal, the existing version of the 2020 Plan will remain in effect, unchanged.

    If a quorum is present, approval Approval of the material terms of the Amended and Restated 2020 Plan requires the affirmative vote of a majority of the shares of our Common Stock represented, in person or by proxy, and entitled to vote at the Special Meeting present and voting at the Annual Meeting in person or by proxy. Unless marked to the contrary, proxies received will be voted “FOR” approval of the Amended and Restated 2020 Plan.

    Get the next $CNXC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNXC

    DatePrice TargetRatingAnalyst
    3/24/2025$70.00 → $54.00Outperform
    Barrington Research
    10/3/2024$70.00Outperform
    Robert W. Baird
    8/28/2024$65.00 → $85.00Underperform → Neutral
    BofA Securities
    3/27/2024$85.00 → $60.00Neutral → Underperform
    BofA Securities
    9/6/2023$70.00Neutral
    Redburn Atlantic
    8/24/2023$120.00Sector Outperform
    Scotiabank
    6/29/2023Buy → Neutral
    BofA Securities
    4/12/2023$150.00Buy
    Canaccord Genuity
    More analyst ratings

    $CNXC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Caldwell Christopher A bought $37,070 worth of shares (1,000 units at $37.07), increasing direct ownership by 0.28% to 362,075 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    2/2/26 4:32:18 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    President and CEO Caldwell Christopher A bought $40,000 worth of shares (1,000 units at $40.00), increasing direct ownership by 0.35% to 287,661 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    11/3/25 4:19:10 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    President and CEO Caldwell Christopher A gifted 20,684 shares and bought $84,056 worth of shares (2,000 units at $42.03), decreasing direct ownership by 6% to 286,661 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    10/31/25 4:50:31 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentrix Achieves Highest Score from The Carbon Disclosure Project (CDP)

    NEWARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, announced today it has earned an ‘A' score for Climate Change leadership from CDP, the global non-profit authority on environmental disclosure. Ranked among nearly 20,000 companies assessed worldwide in 2025, Concentrix stands in the top 2% for environmental responsibility. The CDP ‘A List' is chosen through a rigorous, independent assessment of companies based on transparency, risk management, and evidence of environmental best practices such as ambitious target-setting and verified action. In recent years, Concentrix has set ambitious goals, including validat

    1/27/26 9:05:00 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix Named a Leader in GenAI-Powered Business Transformation

    NEWARK, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced it has been named a Leader in NelsonHall's 2025 NEAT research for Transforming Business Operations with GenAI. This recognition highlights Concentrix' success in helping its clients reimagine their operations to create simpler, smarter customer interactions using Generative AI (GenAI) technologies. The assessment considered how well companies can deliver results both today and in the future. In the 2025 evaluation, Concentrix ranked as a leader in both categories, for its strong work in GenAI innovation, operational transformation, and delivering

    1/20/26 9:05:00 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix Reports Fourth Quarter and Fiscal Year 2025 Results

    Exceeds fourth quarter and fiscal year revenue guidance Delivers record cash flow from operations of $807 million and adjusted free cash flow of $626 million in the fiscal yearReturns $258 million to shareholders in fiscal 2025 through share repurchases and dividends while paying down debtIntroduces 2026 guidance indicating ongoing revenue growth and adjusted free cash flow expansion NEWARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2025.  Three Months Ended   Fiscal Year Ended   November 30, 2025 November 30, 202

    1/13/26 7:30:00 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Concentrix Corporation

    SCHEDULE 13D/A - Concentrix Corp (0001803599) (Subject)

    1/30/26 4:15:02 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by Concentrix Corporation

    10-K - Concentrix Corp (0001803599) (Filer)

    1/28/26 4:07:35 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Concentrix Corp (0001803599) (Filer)

    1/13/26 7:33:15 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Global Ops & Delivery Twomey Cormac J covered exercise/tax liability with 1,439 shares, decreasing direct ownership by 2% to 56,995 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    2/3/26 4:09:38 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    President and CEO Caldwell Christopher A covered exercise/tax liability with 5,693 shares, decreasing direct ownership by 2% to 356,382 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    2/3/26 4:08:48 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Valentine Andre S covered exercise/tax liability with 864 shares, decreasing direct ownership by 0.99% to 86,566 units (SEC Form 4)

    4 - Concentrix Corp (0001803599) (Issuer)

    2/3/26 4:07:32 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barrington Research reiterated coverage on Concentrix with a new price target

    Barrington Research reiterated coverage of Concentrix with a rating of Outperform and set a new price target of $54.00 from $70.00 previously

    3/24/25 7:44:03 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Robert W. Baird initiated coverage on Concentrix with a new price target

    Robert W. Baird initiated coverage of Concentrix with a rating of Outperform and set a new price target of $70.00

    10/3/24 7:27:17 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix upgraded by BofA Securities with a new price target

    BofA Securities upgraded Concentrix from Underperform to Neutral and set a new price target of $85.00 from $65.00 previously

    8/28/24 7:38:59 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Leadership Updates

    Live Leadership Updates

    View All

    Concentrix Appoints Ryan Peterson as Executive Vice President and Chief Product Officer

    NEWARK, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a leading global provider of customer experience (CX) services and technologies, today announced the arrival of Ryan Peterson as Executive Vice President and Chief Product Officer. Ryan will join the Concentrix Global Executive Team and report directly to Chris Caldwell, President and CEO. As Chief Product Officer, Ryan's mission will be to design, develop and deploy innovative products at scale across clients and internal operations. Ryan's team will focus on GenAI powered solutions that leverage Concentrix' domain expertise to enhance customer experiences, as well as improve the productivity of Co

    3/5/24 9:00:00 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Financials

    Live finance-specific insights

    View All

    Concentrix Reports Fourth Quarter and Fiscal Year 2025 Results

    Exceeds fourth quarter and fiscal year revenue guidance Delivers record cash flow from operations of $807 million and adjusted free cash flow of $626 million in the fiscal yearReturns $258 million to shareholders in fiscal 2025 through share repurchases and dividends while paying down debtIntroduces 2026 guidance indicating ongoing revenue growth and adjusted free cash flow expansion NEWARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2025.  Three Months Ended   Fiscal Year Ended   November 30, 2025 November 30, 202

    1/13/26 7:30:00 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix Schedules Release of Fourth Quarter and Fiscal Year 2025 Financial Results and Investor Conference Call Webcast

    NEWARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, plans to announce its fourth quarter and fiscal year 2025 financial results before market open on Tuesday, January 13, 2026. The Company also plans to host a conference call and webcast with the investment community later that morning Tuesday, January 13, 2026, at 8:30 am, Eastern Time to discuss its fourth quarter and fiscal year financial results, the Company's strategy for 2026 and to answer analyst questions. The live conference call webcast will be available in listen-only mode in the Investor Relations section of the Concentrix website under "Events and Pr

    12/23/25 4:05:00 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Concentrix Reports Third Quarter 2025 Results

    Delivers revenue above guidance for Q3 and raises full year growth outlookSees strong demand environment for integrated solutionsOn track to return more than $240 million to shareholders in fiscal 2025Increases quarterly dividend NEWARK, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal third quarter ended August 31, 2025.  Three Months Ended   August 31, 2025 August 31, 2024 ChangeRevenue($M)$2,483.3  $2,387.4  4.0%Operating income($M)$147.0  $153.2  (4.0)%Non-GAAP operating income($M) (1)$305.1  $331.0  (7.8)%Operating margin 5.9%  6.4% -50 bpsNon-GAAP opera

    9/25/25 4:05:00 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    $CNXC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Concentrix Corporation

    SC 13G/A - Concentrix Corp (0001803599) (Subject)

    11/12/24 9:55:17 AM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Concentrix Corporation

    SC 13D/A - Concentrix Corp (0001803599) (Subject)

    8/7/24 6:48:08 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Concentrix Corporation (Amendment)

    SC 13G/A - Concentrix Corp (0001803599) (Subject)

    2/13/24 5:02:33 PM ET
    $CNXC
    Computer Software: Prepackaged Software
    Technology